
Acta Crystallographica, Section C: Crystal Structure Communications p. 2030 - 2032 (1999)
Update date:2022-08-04
Topics:
Neels, Antonia
Stoeckli-Evans, Helen
Plasseraud, Laurent
Garcia Fidalgo, Eva
Suess-Fink, Georg
The homologous title molecules, [Ru2Br4(C10H14) 2]·-C6H6, (1), and [Ru2I4(C10H14) 2]·C7H8, (2), consist of arene-ruthenium moieties [Ru-to-ring distances of 1.655 (2) A in (1) and 1.673 (3) A in (2)] with a terminal halogen ligand [Ru - Br 2.548 (1) A in (1) and Ru - I 2.726 (1) A in (2)], held together by two symmetrical halogen bridges [Ru - Br 2.575 (1) A in (1) and Ru - I 2.736 (1) A in (2)]. The arene rings are planar and parallel to each other, and the terminal halogen ligands are coordinated to ruthenium trans with respect to each other. Both molecules possess Ci symmetry.
Contact:+86-13666670345
Address:Agricultural Development Zone, Haining, Jiaxing, Zhejiang
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
WENZHOU M&C FOREIGN TRADE CO.,LTD.
Contact:+86-577-88862917
Address:No.8 Liming West Road,Wenzhou,zhejiang,China
Contact:0086 533 2282832
Address:Zibo,Shandong
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Doi:10.1039/c29710001506
(1971)Doi:10.1055/s-1999-3174
(1999)Doi:10.1021/ic990631y
(2000)Doi:10.1016/S0277-5387(99)00300-9
(1999)Doi:10.1248/cpb.52.1105
(2004)Doi:10.1002/(SICI)1522-2675(19991215)82:12<2260::AID-HLCA2260>3.0.CO;2-Z
(1999)